Margins matter. The more BioScrip (NAS: BIOS) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Margins matter. The more BioScrip (NAS: BIOS) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.

Shares of the home infusion services giant BioScrip (NASDAQ: BIOS) jumped by almost 40% in premarket trading today. Once the market opened, however, the company's stock abruptly reversed course, ...

In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short ...

A month has gone by since the last earnings report for BioScrip (BIOS). Shares have added about 18.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Don't just count the cash, time it. It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When ...

ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today announced that it has completed its acquisition of Critical Homecare Solutions Holdings, Inc. (“CHS”), a leading provider of home ...

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are ...

What: Shares of BioScrip have fallen by nearly 16% today as a result of the company's underwhelming third-quarter earnings report. So what: Bioscrip's third quarter came in with a solid 23% ...

Shares of the home infusion services giant BioScrip (NASDAQ: BIOS) jumped by almost 40% in premarket trading today. Once the market opened, however, the company's stock abruptly reversed course, ...